Sofie Demeyer

2.3k citations
45 papers · 1.3k · h-index 19

Impact in

Papers in

Co-authors
Jan Cools (29 shared papers)Mario Pickavet (12 shared papers)Pieter Audenaert (11 shared papers)Charles E. de Bock (13 shared papers)Ellen Geerdens (10 shared papers)Didier Colle (6 shared papers)Olga Gielen (16 shared papers)Piet Demeester (5 shared papers)
Journals
Blood (8 papers)Haematologica (5 papers)Leukemia (4 papers)Journal of Hematology & Oncology (2 papers)PLoS ONE (2 papers)
Partner nations
BelgiumUnited StatesUnited Kingdom

In The Last Decade

Sofie Demeyer

44 papers receiving 1.3k citations

Peers

Sofie Demeyer
Comparison fields: 5 of 108
  • Hematology 298
  • Public Health, Environmental and Occupational Health 339
  • Genetics 103
  • Cancer Research 141
  • Oncology 211
Replace Ingmar Glauche with:
Ingmar Glauche Germany
Stefan Horn Germany
Ivo Kwee Switzerland
Daniel Catchpoole Australia
Patrik Edén Sweden
Yue Cui China
Syed Abbas Ali United States
Qing Cheng China
Gaofeng Huang China
Asha Das United States
Sofie Demeyer relative to Ingmar Glauche Germany Ingmar Glauche's profile →
Citations per field
00.5×2×3×3.6×
Ingmar Glauche · 1×
Citations per year

Countries citing papers authored by Sofie Demeyer

Since Specialization
Citations

This map shows the geographic impact of Sofie Demeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Demeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Demeyer more than expected).

Fields of papers citing papers by Sofie Demeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Demeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Demeyer. The network helps show where Sofie Demeyer may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofie Demeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofie Demeyer Line = papers co-authored together Sofie Demeyer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Worldwide energy needs for ICT: The rise of power-aware networking
Ghent University Academic Bibliography (Ghent University) ·Mario Pickavet, Willem Vereecken, Sofie Demeyer, Pieter Audenaert, Brecht Vermeulen, Chris Develder, Didier Colle, Bart Dhoedt, Piet Demeester
2008229
2
Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia
Haematologica ·Carmen Vicente, Claire Schwab, Michaël Broux, Ellen Geerdens, Sandrine Degryse, Sofie Demeyer, Idoya Lahortiga, Alfred M. Elliott, Lucy Chilton, Roberta La Starza, Cristina Mecucci, Peter Vandenberghe, Nicholas Goulden, Ajay Vora, Anthony V. Moorman, Jean Soulier, Christine J. Harrison, Emmanuelle Clappier, Jan Cools
2015118
3
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model
Blood ·Sandrine Degryse, Charles E. de Bock, Luk Cox, Sofie Demeyer, Olga Gielen, Nicole Mentens, Kris Jacobs, Ellen Geerdens, Valentina Gianfelici, Gert Hulselmans, Mark Fiers, Stein Aerts, Jules P.P. Meijerink, Thomas Tousseyn, Jan Cools
2014112
4
Safe targeting of T cell acute lymphoblastic leukemia by pathology-specific NOTCH inhibition
Science Translational Medicine ·R. Habets, Charles E. de Bock, Lutgarde Serneels, Inge Lodewijckx, Delphine Verbeke, David Nittner, Rajeshwar Narlawar, Sofie Demeyer, James Dooley, Adrian Liston, Tom Taghon, Jan Cools, Bart De Strooper
201981
5
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development
Cancer Discovery ·Charles E. de Bock, Sofie Demeyer, Sandrine Degryse, Delphine Verbeke, Bram Sweron, Olga Gielen, Roel Vandepoel, Carmen Vicente, Marlies Vanden Bempt, Antonis Dagklis, Ellen Geerdens, Simon Bornschein, Rik Gijsbers, Jean Soulier, Jules P.P. Meijerink, (unknown), Susanna Teppo, Maria Bouvy‐Liivrand, Olli Lohi, Enrico Radaelli, Jan Cools
201872
6
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
Leukemia ·Sandrine Degryse, Charles E. de Bock, Sofie Demeyer, Inge Govaerts, Simon Bornschein, Delphine Verbeke, Kris Jacobs, Steve Binos, David A. Skerrett‐Byrne, Heather C. Murray, Nicole M. Verrills, Pieter Van Vlierberghe, Jan Cools, Matthew D. Dun
201767
7
Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia
Leukemia ·Jolien De Bie, Sofie Demeyer, Llucia Albertí Servera, Ellen Geerdens, Heidi Segers, Michaël Broux, Kim De Keersmaecker, Lucienne Michaux, Peter Vandenberghe, Thierry Voet, Nancy Boeckx, Anne Uyttebroeck, Jan Cools
201867
8
Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia
Blood ·Llucia Albertí Servera, Sofie Demeyer, Inge Govaerts, Toon Swings, Jolien De Bie, Olga Gielen, Marco Brociner, Lucienne Michaux, Johan Maertens, Anne Uyttebroeck, Kim De Keersmaecker, Nancy Boeckx, Heidi Segers, Jan Cools
202047
9
Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
Cancer Cell ·Marlies Vanden Bempt, Sofie Demeyer, Michaël Broux, Jolien De Bie, Simon Bornschein, Nicole Mentens, Roel Vandepoel, Ellen Geerdens, Enrico Radaelli, Beat Bornhäuser, Andreas E. Kulozik, Jules P.P. Meijerink, Jean‐Pierre Bourquin, Charles E. de Bock, Jan Cools
201842
10
Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors
Blood ·Antonis Dagklis, Sofie Demeyer, Jolien De Bie, Enrico Radaelli, Daphnie Pauwels, Sandrine Degryse, Olga Gielen, Carmen Vicente, Roel Vandepoel, Ellen Geerdens, Anne Uyttebroeck, Nancy Boeckx, Charles E. de Bock, Jan Cools
201641
11
The Long Non-coding RNA Flatr Anticipates Foxp3 Expression in Regulatory T Cells
Frontiers in Immunology ·Aleksandra Brajic, Dean Franckaert, Oliver T. Burton, Simon Bornschein, A. Calvanese, Sofie Demeyer, Jan Cools, James Dooley, Susan Schlenner, Adrian Liston
201839
12
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
Blood ·Michaël Broux, Cristina Prieto, Sofie Demeyer, Marlies Vanden Bempt, Llucia Albertí Servera, Inge Lodewijckx, Roel Vandepoel, Nicole Mentens, Olga Gielen, Kris Jacobs, Ellen Geerdens, Carmen Vicente, Charles E. de Bock, Jan Cools
201934
13
Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma
Blood ·Ana Silva, Afonso R. M. Almeida, Ana Cachucho, João Luís Neto, Sofie Demeyer, Mafalda Matos, Thea Hogan, Yunlei Li, Jules P.P. Meijerink, Jan Cools, Ana Rita Grosso, Benedict Seddon, João T. Barata
202131
14
Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL
Blood ·Sandrine Degryse, Simon Bornschein, Charles E. de Bock, Emilie Leroy, Marlies Vanden Bempt, Sofie Demeyer, Kris Jacobs, Ellen Geerdens, Olga Gielen, Jean Soulier, Christine J. Harrison, Stefan N. Constantinescu, Jan Cools
201730
15
The Index-Based Subgraph Matching Algorithm with General Symmetries (ISMAGS): Exploiting Symmetry for Faster Subgraph Enumeration
PLoS ONE ·Maarten Houbraken, Sofie Demeyer, Tom Michoel, Pieter Audenaert, Didier Colle, Mario Pickavet
201426
16
Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system
Leukemia ·Simon Bornschein, Sofie Demeyer, Rocco Stirparo, Olga Gielen, Carmen Vicente, Ellen Geerdens, Bart Ghesquière, Stein Aerts, Jan Cools, Charles E. de Bock
201723
17
Speeding up Martins’ algorithm for multiple objective shortest path problems
4OR ·Sofie Demeyer, Jan Goedgebeur, Pieter Audenaert, Mario Pickavet, Piet Demeester
201323
18
The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia
Clinical Cancer Research ·Delphine Verbeke, Sofie Demeyer, Cristina Prieto, Charles E. de Bock, Jolien De Bie, Olga Gielen, Kris Jacobs, Nicole Mentens, Bronte Manouk Verhoeven, Anne Uyttebroeck, Nancy Boeckx, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools
202021
19
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
Nature Communications ·Koen Debackere, Lukas Marcelis, Sofie Demeyer, Marlies Vanden Bempt, Nicole Mentens, Olga Gielen, Kris Jacobs, Michaël Broux, Gregor Verhoef, Lucienne Michaux, Carlos Graux, Iwona Włodarska, Philippe Gaulard, Laurence de Leval, Thomas Tousseyn, Jan Cools, Daan Dierickx
202121
20
Fault tolerant network design inspired by Physarum polycephalum
Natural Computing ·Maarten Houbraken, Sofie Demeyer, Dimitri Staessens, Pieter Audenaert, Didier Colle, Mario Pickavet
201215

About Sofie Demeyer

Sofie Demeyer is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Molecular Biology, Immunology and Oncology, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (15 papers), Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (7 papers), Data Management and Algorithms (4 papers), Transportation Planning and Optimization (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Hematology (298 citations), Public Health, Environmental and Occupational Health (339 citations), Genetics (103 citations), Cancer Research (141 citations) and Oncology (211 citations). Sofie Demeyer has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Jan Cools, Mario Pickavet, Pieter Audenaert, Charles E. de Bock, Ellen Geerdens, Didier Colle, Olga Gielen, Piet Demeester, Sandrine Degryse and Chris Develder. Their work appears in journals such as Blood, Haematologica, Leukemia, Journal of Hematology & Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingmar GlaucheBreakdown of academic impact, for papers by Stefan HornBreakdown of academic impact, for papers by Ivo KweeBreakdown of academic impact, for papers by Daniel CatchpooleBreakdown of academic impact, for papers by Patrik EdénBreakdown of academic impact, for papers by Yue CuiBreakdown of academic impact, for papers by Syed Abbas AliBreakdown of academic impact, for papers by Qing ChengBreakdown of academic impact, for papers by Gaofeng HuangBreakdown of academic impact, for papers by Asha Das